News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Sanofi-Aventis (France)'s Zentiva CEO Michal To Step Down
June 30, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dow Jones -- Sanofi-Aventis SA said Tuesday that Jiri Michal, the chief executive of Zentiva NV, the Czech-based generics unit of the French-Swiss pharmaceutical company, is stepping down as of July 1 after 36 years at the company.
Twitter
LinkedIn
Facebook
Email
Print
People
Sanofi (France)
MORE ON THIS TOPIC
Layoff Tracker
Kyverna Cut Off 16% of Staff in Q1
May 15, 2025
·
205 min read
·
BioSpace Editorial Staff
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
·
2 min read
·
Dan Samorodnitsky
Drug discovery
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
May 14, 2025
·
2 min read
·
Annalee Armstrong
MASH
GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena
May 14, 2025
·
2 min read
·
Tristan Manalac